BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Alkermes plc 

852 Winter Street

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-609-6000 Fax: n/a


SEARCH JOBS

About Alkermes plc

Alkermes plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to develop innovative medicines that improve patient outcomes. The company has a diversified portfolio of more than 20 commercial drug products and a substantial clinical pipeline of product candidates that address central nervous system (CNS) disorders such as addiction, schizophrenia and depression. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and manufacturing facilities in Gainesville, Georgia; and Wilmington, Ohio. For more information, please visit Alkermes' website at http://www.alkermes.com.

Key Executives
Richard F. Pops
Chairman and Chief Executive Officer

Shane Cooke
President

Kathryn L. Biberstein
Senior Vice President, Government Relations and Public Policy, General Counsel and Secretary, and Chief Compliance Officer

James L. Botkin
Senior Vice President, Operations

Mark Stejbach
Senior Vice President, Chief Commercial Officer

Dennis J. Bucceri
Vice President, Regulatory Affairs

Madeline D. Coffin
Vice President, Human Resources

Elliot W. Ehrich, M.D.
Senior Vice President, Research and Development, and Chief Medical Officer

James M. Frates
Senior Vice President, Chief Financial Officer

Blair C. Jackson
Vice President, Business Development

Michael J. Landine
Senior Vice President, Corporate Development

Rebecca J. Peterson
Senior Vice President, Corporate Communications

Gordon G. Pugh
Senior Vice President, Chief Operating Officer and Chief Risk Officer

Peter Thornton
Senior Vice President, Business Integration


Locations

Alkermes Corporate Headquarters
Connaught House
1 Burlington Road
Dublin 4, Ireland
+353 1 772 8000

The Waltham, Massachusetts Facility
852 Winter Street
Waltham, MA 02451
+1 781 609 6000

The Athlone, Ireland Facility
Monksland, Athlone
Co Westmeath, Ireland
+353 90 649 5000

The Gainesville, Georgia Location
1300 Gould Drive
Gainesville, GA 30504
+1 770 531 8100

The Wilmington, Ohio Location
265 Olinger Circle
Wilmington, OH 45177
+1 937 382 5642


 Key Statistics


Email: mediainfo@alkermes.com
Ownership: Public

Web Site: Alkermes plc
Employees: 1,200
Symbol: ALKS
 




Segment
Drug Delivery





 Company News
Alkermes plc (ALKS) Reports Financial Results for Fiscal Year 2013 and Provides Financial Expectations 5/23/2013 7:45:56 AM    More...
Alkermes plc (ALKS) Announces Data on ALKS 5461 and ALKS 3831 to be Presented at 53rd Annual NCDEU Meeting 5/22/2013 6:56:04 AM    More...
Alkermes plc (ALKS) to Host Conference Call to Discuss Financial Results for Fiscal Year 2013 5/17/2013 7:20:34 AM    More...
Alkermes plc (ALKS) Elects Nancy Wysenski to Board of Directors 5/16/2013 9:02:35 AM    More...
Alkermes plc (ALKS)’s Corporate Presentation to be Webcast at the Bank of America Merrill Lynch 2013 Smid Cap Conference 5/2/2013 8:00:36 AM    More...
Alkermes plc (ALKS) Has Jumped to a New High on Study Results 4/17/2013 7:53:34 AM    More...
Alkermes plc (ALKS)’ Corporate Presentation to be Webcast at Three Upcoming Conferences 2/20/2013 6:10:36 AM    More...
Alkermes plc (ALKS)’ Corporate Presentation to be Webcast at Two Upcoming Conferences 2/6/2013 6:08:34 AM    More...
Elan Corporation PLC (ELN) to Sell Remaining 7.75 Million Shares of Alkermes plc (ALKS) 2/1/2013 6:52:18 AM    More...
Alkermes plc (ALKS) Reports Third Quarter Fiscal 2013 Financial Results 1/31/2013 6:18:42 AM    More...
12345678910...